Not for human consumption. Amid the FDA’s efforts to regulate peptides, communities on platforms like Telegram are conducting their own lab testing and trials, often without clinical backing. Retatrutide, a new frontrunner in weight loss drugs, shows promise with “28.7% […]
“But a new study has found that it may not be a lack of willpower, but a lack of dopamine signaling in response to nutrients – something more prevalent in adults with obesity – that encourages behaviors like high-sugar food […]
Semaglutides came on the scene after last year’s FDA approval. “Until now, doctors didn’t really use medication to treat obesity; the drugs either didn’t work or had too many side effects. … Semaglutide marks the start of a new generation of […]
“This study in mice showed that the compound can combat obesity by restoring function of a hormone called leptin, which plays a key role in the regulation of appetite by letting us know when we’ve had enough to eat.” | learn more
“Like Weight Watchers, SlimFast, Jenny Craig, The Atkins Diet, and countless fads before it, Noom is the new solution to long-term weight loss that everyone is talking about.” | learn more
This already-approved drug [Semaglutide] just showed remarkable results. “Nearly 2,000 participants, at 129 centers in 16 countries, injected themselves weekly with semaglutide or a placebo for 68 weeks. Those who got the drug lost close to 15 percent of their […]
If you had forced me to guess before reading, I would have certainly been wrong. Maybe you’re in the same boat? | learn more